These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11853125)

  • 1. Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models.
    Ottani A; Ferrari F; Giuliani D
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):91-6. PubMed ID: 11853125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
    Ferrari F; Pelloni F; Giuliani D
    Psychopharmacology (Berl); 1993; 113(2):172-6. PubMed ID: 7855178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of eticlopride on cocaine- and DA D2 agonist-induced behavioral effects in rats.
    Ferrari F; Giuliani D
    Pharmacol Biochem Behav; 1996 Mar; 53(3):525-30. PubMed ID: 8866950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.
    Ferrari F; Ottani A; Giuliani D
    Life Sci; 1999; 65(8):823-31. PubMed ID: 10466748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural effects of the dopamine D3 receptor agonist 7-OH-DPAT in rats.
    Ferrari F; Giuliani D
    Pharmacol Res; 1995; 32(1-2):63-8. PubMed ID: 8668649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of penile erection and yawning responses to apomorphine by cannabinoid receptor antagonist in rats.
    da Silva GE; Fernandes MS; Takahashi RN
    Neurosci Lett; 2003 Sep; 349(1):49-52. PubMed ID: 12946584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects induced in rats and chicks by D2 dopamine agonists.
    Ferrari F; Giuliani D
    Physiol Behav; 1993 Oct; 54(4):695-700. PubMed ID: 7902587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.
    Moreno M; Lopez-Moreno JA; Rodríguez de Fonseca F; Navarro M
    Behav Pharmacol; 2005 Sep; 16(5-6):441-6. PubMed ID: 16148449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
    Rodríguez de Fonseca FR; Villanúa MA; Muñoz RM; San-Martin-Clark O; Navarro M
    Neuroendocrinology; 1995 Jun; 61(6):714-21. PubMed ID: 7659195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.
    Bosier B; Sarre S; Smolders I; Michotte Y; Hermans E; Lambert DM
    Neuropharmacology; 2010 Nov; 59(6):503-10. PubMed ID: 20633567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.
    Giuliani D; Ferrari F; Ottani A
    Pharmacol Res; 2000 Jan; 41(1):47-53. PubMed ID: 10600269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
    Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
    Darmani NA
    Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.
    Martín-Calderón JL; Muñoz RM; Villanúa MA; del Arco I; Moreno JL; de Fonseca FR; Navarro M
    Eur J Pharmacol; 1998 Feb; 344(1):77-86. PubMed ID: 9580419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.